About
Cathera, Inc, the first Alembic portfolio company, developed the Phenom family of microcatheters optimized for intracranial navigation. Cathera was acquired by Medtronic in 2018. Palmera, Inc, a second Alembic portfolio company, is developing new therapeutic and novel products for the minimally invasive treatment of stroke that have the potential to improve outcome for patients that are currently treated, as well as widen the scope of patients that can benefit from therapy.
Technologies
Cloudflare DNS
Outlook
Microsoft Office 365
CloudFlare Hosting
WordPress.org
Mobile Friendly
Quantcast
Remote
IoT
Keywords
medical equipment manufacturing
regulatory registration
medical devices
microcatheter optimization
regulatory compliance
cross-functional teams
medical equipment and supplies manufacturing
medical technology
neuroscience
lifesaving interventional procedures
medical device development
biotechnology
healthcare
product quality improvement
healthcare technology
global manufacturing
concurrent engineering
b2b
therapeutic products
neurovascular solutions
interventional neuroradiology
minimally invasive stroke treatment
quality management system
intracranial navigation
microcatheter manufacturing
patient care
minimally invasive therapy
stroke treatment
neurovascular device innovation
medical device incubator
Company Information
-
Employees 24
-
Founded 2018
Location
627 National Ave, Mountain View, California, United States, 94043-2221
